Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 10/12/21
Johnson & Johnson Announces Jessica Moore as Vice President of Investor RelationsPRNewsWire • 10/12/21
J&J's Stoffels, who managed development of the company's COVID-19 shot, is retiringMarket Watch • 10/12/21
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021PRNewsWire • 10/12/21
Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare ConferencePRNewsWire • 10/11/21
Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in NaturePRNewsWire • 10/06/21
3 Reasons To Own Johnson & Johnson But Buy These 2 Faster-Growing High-Yield Blue-Chips TodaySeeking Alpha • 10/06/21
J&J amends FDA EUA submission for COVID-19 booster with data showing 94% protection against moderate to severe illnessMarket Watch • 10/05/21
Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 VaccinePRNewsWire • 10/05/21